TY - JOUR
T1 - Pathway-based personalized analysis of cancer
AU - Drier, Yotam
AU - Sheffer, Michal
AU - Domany, Eytan
PY - 2013/4/16
Y1 - 2013/4/16
N2 - We introduce Pathifier, an algorithm that infers pathway deregulation scores for each tumor sample on the basis of expression data. This score is determined, in a context-specific manner, for every particular dataset and type of cancer that is being investigated. The algorithm transforms gene-level information into pathway-level information, generating a compact and biologically relevant representation of each sample. We demonstrate the algorithm's performance on three colorectal cancer datasets and two glioblastoma multiforme datasets and show that our multipathway-based repre- sentationisreproducible, preserves muchofthe original information, and allows inference of complex biologically significant information. We discovered several pathways that were significantly associated with survival of glioblastoma patients and two whose scores are predictive of survival in colorectal cancer: CXCR3-mediated signaling and oxidative phosphorylation. We also identified a subclass of pro-neural and neural glioblastoma with significantly better survival, and an EGF receptor-deregulated subclass of colon cancers.
AB - We introduce Pathifier, an algorithm that infers pathway deregulation scores for each tumor sample on the basis of expression data. This score is determined, in a context-specific manner, for every particular dataset and type of cancer that is being investigated. The algorithm transforms gene-level information into pathway-level information, generating a compact and biologically relevant representation of each sample. We demonstrate the algorithm's performance on three colorectal cancer datasets and two glioblastoma multiforme datasets and show that our multipathway-based repre- sentationisreproducible, preserves muchofthe original information, and allows inference of complex biologically significant information. We discovered several pathways that were significantly associated with survival of glioblastoma patients and two whose scores are predictive of survival in colorectal cancer: CXCR3-mediated signaling and oxidative phosphorylation. We also identified a subclass of pro-neural and neural glioblastoma with significantly better survival, and an EGF receptor-deregulated subclass of colon cancers.
UR - http://www.scopus.com/inward/record.url?scp=84876261160&partnerID=8YFLogxK
U2 - 10.1073/pnas.1219651110
DO - 10.1073/pnas.1219651110
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 23547110
AN - SCOPUS:84876261160
SN - 0027-8424
VL - 110
SP - 6388
EP - 6393
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 16
ER -